# The Role of Microbiome in Recurrent Obesity Before and After Antibiotic/Placebo Treatment

> **NCT06681246** · NA · RECRUITING · sponsor: **Weizmann Institute of Science** · enrollment: 200 (estimated)

## Conditions studied

- Obesity
- Weight Loss

## Interventions

- **OTHER:** Antibiotic treatment
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06681246
- **Lead sponsor:** Weizmann Institute of Science
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-11
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06681246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06681246, "The Role of Microbiome in Recurrent Obesity Before and After Antibiotic/Placebo Treatment". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06681246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*